Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP + Rituximab, Intrathecal Methotrexate and Radiotherapy in Primary Testicular Non-Hodgkin's Lymphoma
NCT00210379Phase 2Completed
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Nov 2000
- Primary completion
- Nov 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by International Extranodal Lymphoma Study Group. Started Nov 2000; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00210379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210379.